Lonza Group AGLonza Group AGLonza Group AG

Lonza Group AG

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪42.35 B‬USD
0.92USD
‪727.76 M‬USD
‪7.47 B‬USD
Beta (1Y)
0.89

About LONZA N


CEO
Wolfgang Wienand
Website
Headquarters
Basel
Founded
1897
FIGI
BBG000RKFXY9
Lonza Group AG is engaged in the supply of pharmaceutical, healthcare, and life science products. It operates through the following segments: Biologics, Small Molecules, Cell and Gene, Capsule and Health Ingredients, and Corporate. The Biologics segment serves as contract development and manufacturing partner for biopharmaceuticals, catering customers for all clinical and commercial manufacturing needs throughout the product lifecycle. The Small Molecules segment offers small molecule drug substances and intermediates related services. The Cell and Gene segment includes the Cell and Gene Technologies and Bioscience businesses. The Capsule and Health Ingredients segment provides innovative capsules, dosage form solutions, and health ingredients for pharmaceutical and nutraceutical companies. The Corporate segment refers to finance and accounting, legal, communication, information technology, and human resources functions. The company was founded on October 27, 1897 and is headquartered in Basel, Switzerland.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
L
BE635129021
LONZA F.INTL 24/36 MTN
Yield to maturity
3.58%
Maturity date
Apr 24, 2036
L
BE635521566
LONZA F.INTL 24/34 MTN
Yield to maturity
3.47%
Maturity date
Sep 4, 2034
L
BE634382525
LONZA F.INTL 23/33
Yield to maturity
3.42%
Maturity date
May 25, 2033
L
BE635521364
LONZA F.INTL 24/30 MTN
Yield to maturity
3.06%
Maturity date
Sep 4, 2030
L
BE632107671
LONZA F.INTL 20/27
Yield to maturity
2.71%
Maturity date
Apr 21, 2027
L
CH56464206
LONZA SW.FI. 20/26
Yield to maturity
0.92%
Maturity date
Sep 22, 2026

Explore more bonds